Yuhan Corporation ‘certain’ to generate 2 medicines of KRW 100 billion sales

Published: 2017-05-29 13:10:16

Updated: 2017-05-29 13:10:16

Yuhan Corporation, the top sales company in the pharmaceutical industry, is certain to generate 2 super blockbuster medicines with more than KRW 100 billion annual sales.

According to the Yuhan Corporation’s 1^st quarter report, ‘Viread,’ a hepatitis B treatment, recorded KRW 40.355 billion sales.

As becoming a super blockbuster product of KRW 100 billion sales by recording KRW 109.552 billion...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.